This review critically evaluates GSH-responsive nanomedicine, highlighting advancements in drug delivery systems that leverage tumor-specific redox imbalances to enhance therapeutic efficacy and reduce off-target effects
19,28,30 Further research is needed to clarify the role of GLP-1 agonists in cognitive disorders due to variability in study designs, patient populations, and treatment regimens that may contribute to differing outcomes
Gut and metabolic health early findings suggest improvements in the microbiome that track with the metabolic benefits
Wu D, Chen C, Zhang J, Bowers CY, Clarke IJ
Pediatr Dermatol 9:123125 Tavares TS, Meirelles DP, de Aguiar MCF, Caldeira PC (2018) Pigmented lesions of the oral mucosa: a cross-sectional study of 458 histopathological specimens